- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2448EUR$2,789USD£2,117GBP
- Report
- June 2025
- 150 Pages
Global
From €2369EUR$2,699USD£2,049GBP
- Report
- June 2025
- 150 Pages
Global
From €2369EUR$2,699USD£2,049GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,757GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,757GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,757GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,757GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,757GBP
- Report
- January 2026
- 120 Pages
Global
From €4169EUR$4,750USD£3,606GBP
- Report
- September 2025
- 205 Pages
Global
From €4384EUR$4,995USD£3,792GBP
- Report
- September 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- September 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- August 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- October 2025
- 160 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- October 2025
- 160 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- October 2025
- 160 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- October 2025
- 160 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- August 2025
- 150 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- August 2025
- 118 Pages
Global
From €15795EUR$17,995USD£13,661GBP
- Report
- June 2025
- 101 Pages
Global
From €15795EUR$17,995USD£13,661GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more